Intrauterine device

Abstract

An intrauterine device for applying force to a wall of a uterus to promote contraception without blocking the fallopian tubes may include an elongate member formed of a resilient material and having a default expanded configuration and a spring portion disposed approximately at a midpoint between two ends of the elongate member. The IUD may also include two tissue contact members, one tissue contact member disposed at one of the two ends of the elongate member and the other tissue contact member disposed at the other end. The tissue contact members may generate a laterally directed force against the wall of the uterus when the intrauterine device assumes its default expanded configuration.

1 - 19 . (canceled) 
     
     
         20 . An intrauterine device for applying force to a wall of a uterus to promote contraception without blocking the fallopian tubes, the intrauterine device comprising:
 an elongate member formed of Nitinol, having a diameter between 0.010 inch and 0.025 inch, and having a default expanded configuration and a spring portion disposed approximately at a midpoint between two ends of the elongate member; and   two tissue contact members, one of which is disposed at one end of the elongate member and the other of which is disposed at the other end, wherein each tissue contact member comprises a non-porous material and has a surface area of at least 30 mm squared,   wherein the intrauterine device has a width measured from a tip of one tissue contact member to a tip of the other tissue contact member of at least about 40 mm in its expanded configuration outside the uterus.   
     
     
         21 . An intrauterine device as in  claim 20 , wherein the tissue contact members generate a total, laterally directed force against the wall of the uterus of between 0.002 pounds-force and 0.025 pounds-force when the intrauterine device assumes its default expanded configuration within the uterus. 
     
     
         22 . An intrauterine device as in  claim 21 , wherein the tissue contact members generate a total, laterally directed force against the wall of the uterus of between 0.002 pounds-force and 0.015 pounds-force when the intrauterine device assumes its default expanded configuration within the uterus. 
     
     
         23 . An intrauterine device as in  claim 20 , wherein the spring portion comprises a spring having at least one coil formed in the elongate member. 
     
     
         24 . An intrauterine device as in  claim 20 , wherein the default expanded configuration of the elongate member comprises a V-shape, wherein the spring portion is disposed at a vertex of the V-shape, and wherein the elongate member curves laterally from the spring portion to each of the two ends. 
     
     
         25 . An intrauterine device as in  claim 24 , wherein a height of the intrauterine device measured from a bottom of the spring portion to a top of the tissue contact members is at least 25 mm. 
     
     
         26 . An intrauterine device as in  claim 24 , wherein the elongate member further includes at least two bends configured to reduce the amount of laterally directed force, one bend disposed between the spring portion and one of the two ends, and the other bend disposed between the spring portion and the other end. 
     
     
         27 . An intrauterine device as in  claim 20 , wherein the intrauterine device is compressible into a collapsed configuration for positioning within a delivery sheath having an inner diameter of no more than 3.9 mm. 
     
     
         28 . An intrauterine device as in  claim 20 , wherein the elongate member has a diameter of between 0.014 inch and 0.015 inch. 
     
     
         29 . An intrauterine device as in  claim 20 , further comprising at least one additional tissue contact member for contacting the uterine wall at a different location. 
     
     
         30 . An intrauterine device as in  claim 29 , wherein the additional tissue contact member comprises at least one fundus contact member coupled with at least one of the two tissue contact members via an additional Nitinol elongate member for contacting a fundus of the uterus. 
     
     
         31 . An intrauterine device as in  claim 20 , further comprising a substance disposed in an inner channel in the elongate member or in or on the tissue contact members. 
     
     
         32 . An intrauterine device as in  claim 31 , wherein the substance is selected from the group consisting of hormones, spermicides, copper and therapeutic agents. 
     
     
         33 . A system for promoting contraception without blocking the fallopian tubes, the system comprising:
 an elongate, at least partially hollow delivery device having an outer diameter suitable for passing through a cervix;   an intrauterine device preloaded into the delivery device, wherein the intrauterine device comprises:   an elongate member formed of Nitinol, having a diameter between 0.010 inch and 0.025 inch, a compressed configuration for residing in the delivery device, a default expanded configuration, and a spring portion disposed approximately at a midpoint between two ends of the elongate member, and   two tissue contact members, one of which is disposed at one end of the elongate member and the other of which is disposed at the other end, wherein each tissue contact member comprises a non-porous material and has a surface area of at least 30 mm squared,   wherein the intrauterine device has a width measured from a tip of one tissue contact member to a tip of the other tissue contact member of at least 40 mm in its expanded configuration outside the uterus.   
     
     
         34 . (canceled) 
     
     
         35 . A system as in  claim 33 , wherein the delivery device has an inner diameter of no more than 3.9 mm. 
     
     
         36 . A system as in  claim 33 , further comprising a substance for delivering to the uterus through the intrauterine device. 
     
     
         37 . A system as in  claim 36 , wherein the substance is selected from the group consisting of hormones, spermicides, copper and therapeutic agents.